Home600664 • SHA
add
Harbin Pharmaceutical Group Co Ltd
Nakaraang pagsara
¥3.65
Sakop ng araw
¥3.59 - ¥3.67
Sakop ng taon
¥2.54 - ¥4.97
Market cap
9.07B CNY
Average na Volume
55.85M
P/E ratio
13.63
Dividend yield
-
Primary exchange
SHA
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (CNY) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 4.17B | 0.78% |
Gastos sa pagpapatakbo | 826.11M | -13.16% |
Net na kita | 212.93M | 20.48% |
Net profit margin | 5.10 | 19.44% |
Kita sa bawat share | — | — |
EBITDA | 346.87M | 20.82% |
Aktuwal na % ng binabayarang buwis | 19.49% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (CNY) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 2.80B | -1.58% |
Kabuuang asset | 14.09B | -0.38% |
Kabuuang sagutin | 7.79B | -8.76% |
Kabuuang equity | 6.31B | — |
Natitirang share | 2.66B | — |
Presyo para makapag-book | 1.75 | — |
Return on assets | 4.99% | — |
Return on capital | 9.23% | — |
Cash Flow
Net change in cash
| (CNY) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 212.93M | 20.48% |
Cash mula sa mga operasyon | -464.57M | -71.56% |
Cash mula sa pag-invest | -17.57M | -19.17% |
Cash mula sa financing | -271.12M | -314.72% |
Net change in cash | -753.69M | -372.72% |
Malayang cash flow | -513.00M | -5.30% |
Tungkol
Harbin Pharmaceutical Group Co., Ltd. is a Chinese partially state-owned company engaged in the research & development, manufacture, and sale of pharmaceutical products. HPGC medication offerings include traditional Chinese medicine and biopharmaceuticals; its main offerings include antibiotics, including amoxicillin and penicillin, and dietary supplements, including zinc gluconate and calcium gluconate.
The company owns both Renmintongtai, a drugstore chain and medical wholesaler for the domestic market, and GNC, a U.S.-based international retailer of supplements and wellness products. Wikipedia
Itinatag
1988
Website
Mga Empleyado
10,180
